0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of General Psychiatry |

This Month in Archives of General Psychiatry FREE

Arch Gen Psychiatry. 2005;62(10):1069. doi:10.1001/archpsyc.62.10.1069.
Text Size: A A A
Published online

Cannon et alArticle examined functional activations of the brain regions during working memory processing in patients with schizophrenia and healthy control subjects. When task demands required explicit manipulation of information held in memory or maintenance of 5 or more locations, healthy subjects recruited right dorsolateral prefrontal cortex to a significantly greater extent than patients with schizophrenia. The differences persisted when comparing conditions in which the 2 groups were equivalent in behavioral accuracy.

Traditionally, the search for genes involved in psychoses has proceeded with separate studies of schizophrenia and bipolar disorder. Hamshere et alArticle have undertaken a search for loci that confer risk to an intermediate form of psychosis using a genome-wide linkage scan in families including at least 1 member with DSM-IV schizoaffective disorder, bipolar type. Their findings strongly support the existence of loci that influence susceptibility across the psychosis spectrum.

The prevalence of depressive symptoms co-occurring with hypomanic symptoms has not been quantified. Suppes et alArticle prospectively studied a large cohort of patients with bipolar disorder. The majority of visits met a priori criteria for mixed hypomania. Patients with bipolar I disorder were more likely than those with bipolar II disorder to experience hypomania. Both men and women were significantly likely to experience mixed symptoms when hypomanic, and this was significantly more likely in women. When overlapping items of the mania and depression scales were eliminated, the significant effect persisted only for women.

In a national sample of 43 093 adults surveyed in 2002, Hasin et alArticle studied the epidemiology of major depressive disorder (MDD). A changed age distribution was found, with higher lifetime rates in the baby boom birth cohorts than in the youngest respondents. Ethnic group differences included a high risk for MDD in Native American individuals and a lower risk of MDD in Hispanic and Asian individuals, notwithstanding treatment disparities. Major depressive disorder was strongly related to substance dependence but not substance abuse. New information on MDD and personality disorders is presented.

Zhou et alArticle linked the tryptophan hydroxylase 2 (TPH2) gene to major depression and suicide attempts in several populations. TPH2 is principally encompassed by 1 large haplotype block within which a common haplotype is associated with vulnerability. This same haplotype is also moderately predictive of low levels of cerebrospinal fluid 5-hydroxyindoleacetic acid, an intermediate phenotype for suicide and depression.

Mental disorders occur in an overwhelming majority of self-injurious youth. Yet Olfson et alArticle report that mental disorders are diagnosed in only 56% of emergency department visits by self-injurious young people, aged 7 to 24 years. A minority of these emergency visits include a mental status examination. This suggests substantial underrecognition of mental illness and an urgent need to strengthen emergency department mental health assessments of young people who deliberately harm themselves.

Bekker et alArticle presented the stop signal task to 24 adults with attention-deficit/hyperactivity disorder combined subtype and 24 matched controls. In patients, stop signal reaction times were elongated, whereas go stimulus reaction times were unaffected. Overlap-free event-related potentials indicated smaller stop P3s. Larger N1 amplitudes for successful vs failed stops were found in controls but not in patients. This suggests that disturbed attentional processing of the stop signal contributes to impaired stopping in adults with attention-deficit/hyperactivity disorder.

Kollins et alArticle assessed the relationship between retrospectively reported attention-deficit/hyperactivity disorder (ADHD) symptoms and smoking outcomes in a sample of 15 197 young adults who were part of the Add Health national survey. Analyses showed that ADHD symptoms, even at levels below clinical threshold, were positively and linearly related to risk of lifetime smoking and the amount of current smoking. The ADHD symptoms were negatively and linearly related to the age at onset of regular smoking.

Petry et alArticle describe outcomes from a multicenter Clinical Trials Network study of stimulant abusers. Participants received standard care in community clinics, and half were randomized to a relatively low-cost incentive condition in which they also received the opportunity to win prizes for maintaining abstinence. Participants in the incentive condition remained in treatment longer and attained greater abstinence than those receiving standard care alone. Provision of contingent, tangible incentives improved outcomes of substance abusers.

Marsch et alArticle evaluated the relative efficacy of the partial opioid agonist buprenorphine hydrochloride and the centrally active α2-adrenergic blocker clonidine hydrochloride in the detoxification of opioid-dependent adolescents when provided with behavioral treatment. A volunteer sample of 36 adolescents who met criteria for opioid dependence (ages 13-18 eligible) were randomly assigned to a 28-day, outpatient, medication-assisted withdrawal treatment with either buprenorphine or clonidine. Buprenorphine produced markedly greater treatment retention, opiate abstinence, and positive medication effects.

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.